Inhaled short-acting bronchodilators for managing emergency childhood asthma: an overview of reviews

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 72, Issue 2, 2017, Pages 183-200

  Pollock, M ^a   Sinha, I P ^b   Hartling, L ^a   Rowe, B H ^c   Schreiber, S ^a   Fernandes, R M ^d,e  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF LISBON   (Portugal)

^e HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

asthma; bronchodilator; children; emergency department; overview of reviews

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; EPINEPHRINE; LEVALBUTEROL; MAGNESIUM SULFATE; SALBUTAMOL; SHORT ACTING DRUG; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

AGE; ASTHMA; CHILD; DRUG EFFICACY; DRUG SAFETY; EMERGENCY TREATMENT; HUMAN; LENGTH OF STAY; METERED DOSE INHALER; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); WHEEZING; ADOLESCENT; COMBINATION DRUG THERAPY; DISEASE MANAGEMENT; EMERGENCY HEALTH SERVICE; INFANT; INHALATIONAL DRUG ADMINISTRATION; META ANALYSIS; NEWBORN; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; EMERGENCY MEDICAL SERVICES; HUMANS; INFANT; INFANT, NEWBORN; TREATMENT OUTCOME;

EID: 84990857210     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13039     Document Type: Review

References (37)

1. Weiss AJ, Wier LM, Stocks C, Blanchard J. Overview of emergency department visits in the United States, 2011. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
2. National Health Service England. NHS atlas of variation in healthcare 2015. Map 83: Emergency asthma admission rate for children aged 0–18 years per 100,000 population by CCG, 2012/13. 2015. Available from: http://www.rightcare.nhs.uk/atlas/2015_IAb/atlas.html [cited 12 March 2016].
3. Lyttle MD, O'Sullivan R, Doull I, Hartshorn S, Morris I, Powell CV. Variation in treatment of acute childhood wheeze in emergency departments of the United Kingdom and Ireland: an international survey of clinician practice. Arch Dis Child 2015;100:121–125.
4. Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and therapeutics of bronchodilators. Pharmacol Rev 2012;64:450–504.
5. Neame M, Aragon O, Fernandes RM, Sinha I. Salbutamol or aminophylline for acute severe asthma: how to choose which one, when and why? Arch Dis Child 2015;100:215–222.
6. Becker LA, Oxman AD. Chapter 22: overviews of reviews. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions (version 5.1.0). The Cochrane Collaboration, 2011.
7. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
8. Green S, Higgins JPT, Alderson P, Clarke M, Mulrow CD, Oxman AD. Chapter 1: introduction. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions (version 5.1.0). The Cochrane Collaboration, 2011.
9. Boluyt N, Tjosvold L, Lefebvre C, Klassen TP, Offringa M. Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. Arch Pediatr Adolesc Med 2008;162:111–116.
10. Montori VM, Wilczynski NL, Morgan D, Haynes RB. Optimal search strategies for retrieving systematic reviews from Medline: analytical survey. BMJ 2005;330:68.
11. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol 2009;62:1013–1020.
12. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions (version 5.1.0). The Cochrane Collaboration, 2011.
13. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998;17:873–890.
14. Schunemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P et al. Chapter 12: interpreting results and drawing conclusions. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions (version 5.1.0). The Cochrane Collaboration, 2011.
15. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–926.
16. Schunemann HJ, Brozek J, Guyatt GH, Oxman AD. GRADE handbook for grading quality of evidence and strength of recommendations. 2013. Available from: http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html#h.ygojbnr1bi5y [cited 12 April 2016].
17. Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013;9:CD000052.
18. Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2013;8:CD010283.
19. Powell C, Dwan K, Milan SJ, Beasley R, Hughes R, Knopp-Sihota JA et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2012;12:CD003898.
20. Teoh L, Cates CJ, Hurwitz M, Acworth JP, Van Asperen P, Chang AB. Anticholinergic therapy for acute asthma in children. Cochrane Database Syst Rev 2012;4:CD003797.
21. Everard M, Bara A, Kurian M, Elliott T, Ducharme F, Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev 2005;3:CD001279.
22. Camargo CA Jr, Spooner C, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database Syst Rev 2003;4:CD001115.
23. Chavasse RJ, Seddon P, Bara A, McKean MC. Short acting beta2-agonists for recurrent wheeze in children under two years of age. Cochrane Database Syst Rev 2002;4:CD002873.
24. Jat KR, Khairwa A. Levalbuterol versus albuterol for acute asthma: a systematic review and meta-analysis. Pulm Pharmacol Ther 2013;26:239.
25. Shan Z, Rong Y, Yang W, Wang D, Yao P, Xie J et al. Intravenous and nebulized magnesium sulfate for treating acute asthma in adults and children: a systematic review and meta-analysis. Respir Med 2013;107:321–330.
26. Rodrigo GJ, Nannini LJ. Comparison between nebulized adrenaline and β2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials. Am J Emerg Med 2006;24:217–222.
27. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005;60:740–746.
28. Castro-Rodriguez JA, Rodrigo GJ. β-Agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr 2004;145:172–177.
29. Amirav I, Newhouse MT. Metered-dose inhaler accessory devices in acute asthma: efficacy and comparison with nebulizers: a literature review. Arch Pediatr Adolesc Med 1997;151:876–882.
30. British Thoracic Society. British guideline on the management of asthma. A national clinical guideline. London: British Thoracic Society; 2014.
31. Global Initiative for Asthma (GINA). The global strategy for asthma management and prevention. Global Initiative for Asthma (GINA); 2016.
32. Osmond MH, Gazarian M, Henry RL, Clifford TJ, Tetzlaff J. Barriers to metered-dose inhaler/spacer use in Canadian pediatric emergency departments: a national survey. Acad Emerg Med 2007;14:1106–1113.
33. Scott SD, Osmond MH, O'Leary KA, Graham ID, Grimshaw J, Klassen T. Barriers and supports to implementation of MDI/spacer use in nine Canadian pediatric emergency departments: a qualitative study. Implement Sci 2009;4:65.
34. Cotterell EM, Gazarian M, Henry RL, O'Meara MW, Wales SR. Child and parent satisfaction with the use of spacer devices in acute asthma. J Paediatr Child Health 2002;38:604–607.
35. Leversha AM, Campanella SG, Aickin RP, Asher MI. Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr 2000;136:497–502.
36. Ploin D, Chapuis FR, Stamm D, Robert J, David L, Chatelain PG et al. High-dose albuterol by metered-dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: a double-blind, randomized equivalence trial. Pediatrics 2000;106:311–317.
37. Castro-Rodriguez JA, Rodrigo GJ, Rodriguez-Martinez CE. Principal findings of systematic reviews for chronic treatment in childhood asthma. J Asthma 2015;52:407–416.